Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Inventory (2023 - 2025)

Historic Inventory for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $20.4 million.

  • Beta Bionics' Inventory changed N/A to $20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year change of. This contributed to the annual value of $13.3 million for FY2024, which is 96987.95% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Inventory is $20.4 million.
  • Beta Bionics' 5-year Inventory high stood at $20.4 million for Q3 2025, and its period low was $1.2 million during Q4 2023.
  • Over the past 3 years, Beta Bionics' median Inventory value was $15.7 million (recorded in 2025), while the average stood at $13.6 million.
  • Within the past 5 years, the most significant YoY rise in Beta Bionics' Inventory was 96987.95% (2024), while the steepest drop was 96987.95% (2024).
  • Over the past 3 years, Beta Bionics' Inventory (Quarter) stood at $1.2 million in 2023, then surged by 969.88% to $13.3 million in 2024, then skyrocketed by 52.95% to $20.4 million in 2025.
  • Its Inventory was $20.4 million in Q3 2025, compared to $17.3 million in Q2 2025 and $15.7 million in Q1 2025.